What Is Going on With Cassava (SAVA) Stock Today?

SAVA stock remains volatile as speculators place bets on Simufilam, Cassava Sciences's Alzheimer's drug under Phase 3 study.

Related Keywords

New York ,United States ,New Yorker ,Remi Barbier ,Exchange Commission ,Cassava Sciences ,Pain Therapeutics ,Speculators See ,January New Yorker ,